Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Afamelanotide, Photo-Protective Drug

Drug

Afamelanotide

Company

Clinuvel Pharmaceuticals

Therapy Class

Photoprotective drugs

Product Description

Prophylactic treatment for skin disorders

Current Indication

Erythropoietic protoporphyria, photodynamic therapy, solar urticaria, actinic keratosis / squamous cell carcinoma and polymorphous light eruption

Market Sector

Dermatology

Development Status

Phase III confirmatory study under progress, received ODD status from the FDA and EMEA, granted IND status by the FDA
Expand

Free download worth over $5000
Download our 2019 Technology, Media and Telecoms Predictions Report

Worth up to $5,850

In this report, we look at the 30 big tech themes for 2019, identifying winners and losers for each theme. This report will impact all industries helping:

  • CEOs/Senior Staff: in all industries understand the disruptive threats to their competitive landscape
  • Investors: Helps fund managers focus their time on the most interesting investment opportunities in global TM

Go Top